In an Expert View column.Bruce Leuchter.chief executive of Neurvati Neurosciences.a Blackstone Life Sciences portfolio company.outlines the importance of increa 17 May 2024
Japanese drugmaker Ono Pharmaceutical has received supplemental approvals for the BRAF inhibitor Braftovi (encorafenib), and the MEK inhibitor Mektovi (binimeti 17 May 2024
German drugmaker Bayer will present positive results from the OASIS 1 and 2 studies at the annual meeting of the American College of Obstetricians and Gynecolog 17 May 2024
Jo Latimer.head of neurosciences and mental health at the UK’s Medical Research Council (MRC).has been appointed chief scientific officer at a charity performin 16 May 2024
US pharma major Eli Lilly (NYSE: LLY) has provided an update on compounding litigation relating to tirzepatide, its drug for type 2 diabetes and weight loss tha 16 May 2024
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news
Company Spotlight
USA-based Insmed (NASDAQ CM: INSM) is a biopharmaceutical company on the development and commercialization of novel, targeted inhaled therapies for patients with serious rare diseases.